abstract |
The present invention relates to compounds,nmethods and pharmaceutical compositions for inhibitingnproteases, particularly serine proteases, and morenparticularly HCV NS3 proteases. The compounds, and thencompositions and methods that utilize them, can be used,neither alone or in combination to inhibit viruses,nparticularly HCV virus. |